Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 8431-8440 of 13616

Page
per page
  1. MK-4827 tosylate
    B1164 MK-4827 tosylate
    Summary: PARP1/PARP2 inhibitor
      ≥51.4 mg/mL
  2. Akt Inhibitor IV
    C5867 Akt Inhibitor IV
      ≤30 mg/mL
  3. ML385
    B8300 ML385
     22 Citation
    Summary: NRF2 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥13.33 mg/mL
  4. Qstatin
    B8522 Qstatin
    Summary: A potent and selective SmcR inhibitor
      ≥28.7 mg/mL
  5. BGP-15
    B6086 BGP-15
    Summary: PARP inhibitor
      ≥14.55 mg/mL
  6. BH3I-1
    B6094 BH3I-1
    Summary: Bcl-2 or Bcl-XL inhibitor
      ≥40 mg/mL
  7. PIK-III
    B6160 PIK-III
     1 Citation
    Summary: VPS34 inhibitor and inhibits autophagy
      ≥31.9 mg/mL
  8. Piperaquine
    C3188 Piperaquine
    Summary: used in combination with artimesinin for inhibition of HIV-1 replication
      ≤0.2 mg/mL
  9. NCT-503
    C3853 NCT-503
     1 Citation
    Summary: 3-phosphoglycerate dehydrogenase (PHGDH) inhibitor
      ≥40.9 mg/mL
  10. OXA-01
    C4204 OXA-01
    Summary: mTORC1 and mTORC2 inhibitor
      ≤3 mg/mL

Items 8431-8440 of 13616

Page
per page